Clinical trial
Effect of Tvns in Obesity
Active, not recruiting · Not applicable · 1 countries · Registry ID NCT07334951
Active, not recruitingNot applicableInterventional
What this study is about
Avoid unhealthy foods, walk every day for at least 15 min , sleep well, he should take sessions at its time, family should Avoid disturbances, keep quiet as much as possible, make Analysis recoired before and after interaction.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age40 Years to 50 Years
SexAll
Healthy volunteersNot accepted
ConditionObesity and Diabetes Mellitus, Type 2
Full registry criteria
Inclusion Criteria:40\_50years Both sexes , BMI more than or equal 30 kg/m2 FBG less than 7 mmol/l 2hpp between 7.8 and 11.1mmol/l at the time of enrollment . HOMA-IR \>2.9 All are sedentary level activities. Exclusion Criteria:Diagnostic type 1and 2 DM Cardiovascular disease, stroke, uncontrolled hypertension Use psychoactive drugs, antiepliptic drugs, antidepressants. Present of metal implants, pace maker or cochlear implants. History of epilepsy or seizours . Pregnancy or breast feeding. Dermatologist condition near stimulating site. Major psychiatric disorders. \-
Treatments and study arms
Trans vagus nerve stimulation electrical device.
Device
Tvns located at auricular concha area For 45min three times per week for 3 months.
Primary outcomes
Glucose tolerance.Baseline and after 12th weeks of intervention.
Change in glucose tolerance assessed using 2\_hours oral glucose tolerance test (OGTT), expressed as glucose plasma area under curve (AUC), following a75 g oral glucose load.
Study locations
1 locations were listed when this page was built. The first 40 are shown.
Tanta general hospital🇪🇬 Tanta, Algarbia, Egypt